Exploring Reasonable Extension of Secukinumab Dosing Intervals in Real-World Settings

Published: 5 November 2025| Version 2 | DOI: 10.17632/fmy4kyhh3z.2
Contributors:
,
,
,
,
,
,
,
,
,
,
,
,
,

Description

Supplemental material for "Exploring Reasonable Extension of Secukinumab Dosing Intervals in Real-World Settings".

Files

Institutions

Shandong Provincial Institute of Dermatology and Venereology

Categories

Biologic Agent, Psoriasis, Real-World Knowledge

Licence